The Departments of Pharmacology and
Ophthalmology and Visual Sciences at Case Western
Reserve University (CWRU) School of Medicine have
received a $10.1 million grant from the National Eye
Institute (NEI) to research and develop new treatments
for reti…
Ozurdex Reduced Inflammation, Improved Visual Acuity in Uveitic Eyes
The Ozurdex dexamethasone intravitreal implant
(Allergan, Inc.) significantly improved intraocular inflammation
and visual acuity in patients with noninfectious
intermediate or posterior uveitis, according to a study in
the Archives of Ophthalmology.1
…
Postoperative Oral Steroids Reduced Subretinal Fluid
Postoperative systemic steroid treatment decreased the
incidence and facilitated the absorption of subretinal fluid (SRF), according to a study in Retina.1 Patients treated
with steroids also had a greater improvement in BCVA.
In the prospective, inter…
Ifa Systems AG Aquires Inoveon Corporation
Ifa Systems AG (Cologne, Germany), a provider of software
applications in international ophthalmology,
announced the acquisition of Inoveon Corp. (Oklahoma
City, OK), which specializes in detection, staging, and
monitoring of diabetic retinopathy and m…
Prevalence of AMD on the Decline in US Adults
The prevalence of age-related macular degeneration
(AMD) in US adults is significantly lower today than it
was 15 years ago, according to the results of a nationally
representative, population-based, cross-sectional study
published in the Archives of O…
Advanced Cell Technology Receives FDA Clearance to Initiate Clinical Trials
Advanced Cell Technology, Inc. (Santa Monica, CA)
announced that it received clearance from the US Food
and Drug Administration (FDA) for the company’s
Investigational New Drug application to treat dry AMD
using retinal pigment epithelial (RPE) cells…